生物素对甲状腺激素、促甲状腺激素和甲状腺球蛋白检测的干扰
前瞻性研究纳入13名成人,每日口服生物素10 mg共8天,在第1天和第8天三个时间点采血,用四种平台检测甲状腺相关指标。结果发现罗氏Cobas 6000平台上的TSH、fT4和TT3以及西门子IMMULITE 2000上的Tg出现显著改变,最大干扰在摄入后2小时。
要点
- 每日10 mg生物素可干扰TSH、fT4、TT3和Tg的特定检测平台。
- 罗氏Cobas 6000平台在生物素暴露后TSH、fT4和TT3测量值显著改变。
- 西门子IMMULITE 2000平台检测Tg时,生物素导致假性降低。
核心结论
- 每日10 mg生物素可干扰TSH、fT4、TT3和Tg的特定检测方法。
- 医生需警惕服用生物素补充剂者可能出现错误检测结果。
- TSH和Tg结果改变对需精细调整左甲状腺素治疗的患者(如甲状腺癌)尤其棘手。
研究设计与样本
- 前瞻性研究,纳入13名成人(平均年龄45±13岁),每日口服生物素10 mg共8天。
- 第1天和第8天三个时间点(基线、摄入后2小时和5小时)采集血标本。
- 用Abbott Architect、Roche Cobas 6000、Siemens IMMULITE 2000和LC-MS/MS四种平台检测甲状腺相关指标。
主要发现
- 使用罗氏Cobas 6000平台时,生物素暴露后TSH、fT4和TT3测量值出现显著改变。
- 使用西门子IMMULITE 2000平台检测时,生物素摄入导致Tg水平假性降低。
- 第1天和第8天摄入后2小时均观察到最大生物素干扰。
临床怎么用
- 对服用生物素补充剂的患者,应警惕甲状腺功能及Tg检测结果可能失真。
- 需精细调整左甲状腺素治疗的患者(如甲状腺癌)尤应注意生物素干扰风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Biotin has been reported to interfere with several commonly used laboratory assays resulting in misleading values and possible erroneous diagnosis and treatment. This report describes a prospective study of possible biotin interference in thyroid-related laboratory assays, with a comparison of different commonly used assay platforms. Materials and Methods: Thirteen adult subjects (mean age 45 ± 13 years old) were administered biotin 10 mg/day for eight days. Blood specimens were collected at three time points on day 1 and on day 8 (baseline, two, and five hours after biotin ingestion). Thyrotropin (TSH), free triiodothyronine (fT3), free thyroxine (fT4), total triiodothyronine (TT3), total thyroxine (TT4), thyroxine binding globulin (TBG), and thyroglobulin (Tg) levels were analyzed with four different platforms: Abbott Architect, Roche Cobas 6000, Siemens IMMULITE 2000, and liquid chromatography with tandem mass spectrometry (LC-MS/MS). TSH, fT3, fT4, TT3, and TT4 were measured with Abbott Architect and Roche Cobas 6000. fT3, fT4, TT3, and TT4 were also measured by LC-MS/MS. Tg was measured by Siemens IMMULITE 2000. TBG was assessed with Siemens IMMULITE 2000. Results: Significant changes in TSH, fT4, and TT3 measurements were observed after biotin exposure when the Roche Cobas 6000 platform was used. Biotin intake resulted in a falsely lower Tg level when measurements were performed with Siemens IMMULITE 2000. At the time points examined, maximal biotin interference was observed two hours after biotin exposure both on day 1 and day 8. Conclusions: A daily dose of 10 mg was shown to interfere with specific assays for TSH, fT4, TT3, and Tg. Physicians must be aware of the potential risk of erroneous test results in subjects taking biotin supplements. Altered test results for TSH and Tg can be particularly problematic in patients requiring careful titration of levothyroxine therapy such as those with thyroid cancer.
引用
- Ylli D, Soldin SJ, Stolze B, et al. Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin. Thyroid. 2021. PMID: 34042535. doi:10.1089/thy.2020.0866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。